title: [Eradication therapy of antibiotic-resistant strains of Helicobacter pylori].
abstract: Treatment of inflammatory diseases of the upper digestive tract, associated with Helicobacter pylori has recently greatly complicated by the presence of significant number of resistant strains of this microorganism to traditionally used drugs for eradication therapy. Average resistance to metronidazole and clarithromycin in Russia is about 30 and 25% respectively. The article presents the experience of treating patients with metronidazole resistant strains of H. pylori with using triple therapy, which included a drug used nitrofurans--nifuroxazide in suspension, proton pump inhibitors and clarithromycin.
authors.forename: P L
authors.initials: PL
authors.lastname: Shcherbakov
authors.forename: N L
authors.initials: NL
authors.lastname: Belousova
authors.forename: M Iu
authors.initials: MIu
authors.lastname: Shcherbakova
authors.forename: V S
authors.initials: VS
authors.lastname: Kashnikov
mesh_terms: D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D017291:Clarithromycin / Q000008:administration & dosage*; D024881:Drug Resistance, Bacterial / Q000187:drug effects*; D004359:Drug Therapy, Combination / Q000379:methods; D005260:Female; D016481:Helicobacter Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D016480:Helicobacter pylori; D006801:Humans; D062385:Hydroxybenzoates / Q000008:administration & dosage*; D008297:Male; D008795:Metronidazole; D008875:Middle Aged; D009581:Nitrofurans / Q000008:administration & dosage*; D054328:Proton Pump Inhibitors / Q000008:administration & dosage*
chemical_list: D000900:Anti-Bacterial Agents; D062385:Hydroxybenzoates; D009581:Nitrofurans; D054328:Proton Pump Inhibitors; D008795:Metronidazole; D017291:Clarithromycin; C013150:nifuroxazide